BIVV003
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for BIVV003, covering 2025-09-12 to 2025-11-12. Get the full timeline:
Most recent: Clinical Trial Update: Long - Term Follow Up of Sickle Cell Disease and Beta-thalassemia Subjects Previously Exposed to BIVV003 or ST-400.